A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/18 (2006.01) A61K 31/00 (2006.01) A61K 31/12 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/557 (2006.01) A61K 45/00 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2349427
Anti-inflammatory agents are used to prevent iridial pigmentation during prostaglandin treatment and to manufacture pharmaceuticals for this purpose. A method for preventing iridial pigmentation as well as a method for treating glaucoma is based on the concomitant or simultaneous administration of a prostaglandin or prostaglandin analogue and an anti-inflammatory agent. Both non-steroid and steroid anti-inflammatory agents can be employed according to the invention.
L'invention concerne des agents anti-inflammatoires qu'on utilise pour prévenir la pigmentation iridienne au cours d'un traitement à la prostaglandine, et pour fabriquer des médicaments à cette fin. Une méthode de prévention de la pigmentation iridienne et de traitement du glaucome est fondée sur l'administration concomitante ou simultanée d'une prostaglandine ou son analogue et d'un agent anti-inflammatoire. Selon l'invention, des agents anti-inflammatoires tant stéroïdiens que non stéroïdiens peuvent être employés.
Resul Bahram
Stjernschantz Johan
Fetherstonhaugh & Co.
Synphora Ab
LandOfFree
Method for preventing increased iridial pigmentation during... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing increased iridial pigmentation during..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing increased iridial pigmentation during... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1904172